Pediatrics - Global Neurology Academy

1-16 of 53

Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
NeuroFrontiers
Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
Alexandria May, PharmD, BCPS; Kaitlin Batley, MD
- Alexandria May, PharmD, BCPS
- Kaitlin Batley, MD
Advancing Pediatric MS Care: Insights from AAN 2026
Advancing Pediatric MS Care: Insights from AAN 2026
NeuroFrontiers
Advancing Pediatric MS Care: Insights from AAN 2026
Elizabeth Wilson, MD
- Elizabeth Wilson, MD
Switching to Risdiplam Maintains Motor Gains in SMA Patients
Switching to Risdiplam Maintains Motor Gains in SMA Patients
AudioAbstracts
Switching to Risdiplam Maintains Motor Gains in SMA Patients
Ryan Quigley
- Ryan Quigley
Understanding Accelerated Biological Aging in Pediatric MS
Understanding Accelerated Biological Aging in Pediatric MS
NeuroFrontiers
Understanding Accelerated Biological Aging in Pediatric MS
Jennifer Yang, MD
- Jennifer Yang, MD
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Project Oncology®
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Alexandria May, PharmD, BCPS; Nicholas Whipple, MD, MPH
- Alexandria May, PharmD, BCPS
- Nicholas Whipple, MD, MPH
How Daily Light Habits Influence Migraine in Adolescents
How Daily Light Habits Influence Migraine in Adolescents
Global Neurology Academy
How Daily Light Habits Influence Migraine in Adolescents
Charles Turck, PharmD, BCPS, BCCCP; Carlyn Patterson Gentile, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Carlyn Patterson Gentile, MD
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
CME/CE
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
Stephen Chrzanowski, MD, PhD; Aravindhan Veerapandiyan, MD
1.00 credit
- Stephen Chrzanowski, MD, PhD
- Aravindhan Veerapandiyan, MD
1.00 credit
Genetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
Genetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
Clinician's Roundtable
Genetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
Jennifer M. Kalish, MD, PhD, FAAP
- Jennifer M. Kalish, MD, PhD, FAAP
Addressing Barriers to MenB and MenACWY Vaccination
Addressing Barriers to MenB and MenACWY Vaccination
Global Neurology Academy
Addressing Barriers to MenB and MenACWY Vaccination
Evaluating MenB Vaccines Beyond the Traditional hSBA Assay
Evaluating MenB Vaccines Beyond the Traditional hSBA Assay
Global Neurology Academy
Evaluating MenB Vaccines Beyond the Traditional hSBA Assay
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings from the MAPLE-MS Pharmacovigilance Program
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings from the MAPLE-MS Pharmacovigilance Program
NeuroFrontiers
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings from the MAPLE-MS Pharmacovigilance Program
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
NeuroFrontiers
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
NeuroFrontiers
Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
Exploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
Exploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
NeuroFrontiers
Exploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
Quantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
Quantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
NeuroFrontiers
Quantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
Cardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
Cardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
NeuroFrontiers
Cardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy

Prev
1
2
3
4
Next

1/4